Overview
Robert Underwood, commenting on a court battle over patent rights to a revolutionary gene-editing technology called CRISPR-cas9, said that “part of what makes it such a fun spectator sport is the amount of money that’s at stake. These could potentially be the most valuable biotech patents ever.”